Integer (NYSE:ITGR) Upgraded at Citigroup

Citigroup upgraded shares of Integer (NYSE:ITGR - Free Report) from a hold rating to a strong-buy rating in a report published on Thursday morning, MarketBeat.com reports. They currently have $140.00 price objective on the medical equipment provider's stock, up from their prior price objective of $133.00.

Several other research analysts have also commented on the company. Raymond James boosted their price target on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Benchmark reduced their target price on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Truist Financial set a $150.00 target price on Integer and gave the company a "buy" rating in a report on Friday, April 25th. Finally, Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Integer has an average rating of "Moderate Buy" and an average target price of $145.00.

Integer Stock Up 0.2%

Shares of NYSE ITGR traded up $0.27 during trading on Thursday, reaching $118.43. The company had a trading volume of 244,616 shares, compared to its average volume of 372,916. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer has a 12-month low of $104.93 and a 12-month high of $146.36. The stock has a market cap of $4.13 billion, a PE ratio of 35.25, a P/E/G ratio of 1.72 and a beta of 1.03. The business's 50-day moving average is $118.40 and its 200 day moving average is $129.17.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 earnings per share. As a group, equities analysts forecast that Integer will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at $5,788,990. This represents a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.16% of the stock is currently owned by company insiders.

Institutional Trading of Integer

Hedge funds have recently modified their holdings of the stock. Mather Group LLC. raised its stake in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of Integer in the fourth quarter valued at $27,000. Opal Wealth Advisors LLC acquired a new stake in shares of Integer in the first quarter valued at $28,000. AdvisorNet Financial Inc acquired a new stake in shares of Integer in the first quarter valued at $28,000. Finally, SVB Wealth LLC acquired a new stake in shares of Integer in the first quarter valued at $35,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.